| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on January 16, 2007
Accepted on July 11, 2007
cell function
Department of Internal Medicine and Therapeutics, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, 565-0871 Japan, Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, 723 Light Hall, Nashville, TN 37232, Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, 371-8512 Japan
* To whom correspondence should be addressed. E-mail: takaaki{at}medone.med.osaka-u.ac.jp.
Insulin transcription factor MafA is unique in being exclusively expressed at the secondary and principal phase of insulin-expressing cell production during pancreas organogenesis, and is the only transcriptional activator present exclusively in islet
cells. Here we show that ectopic expression of MafA is sufficient to induce a small amount of endogenous insulin expression in a variety of non-
cell lines. Insulin mRNA and protein expression was induced to a much higher level when MafA was provided with two other key insulin activators, PDX-1 and BETA2. Potentiation by PDX-1 and BETA2 was entirely dependent upon MafA, and MafA binding to the insulin enhancer region was increased by PDX-1 and BETA2. Treatment with activin A and HGF induced even larger amounts of insulin in AR42J pancreatic acinar cells, compared with other non-
endodermal cells. The combination of PDX-1, BETA2, and MafA also induced the expression of other important regulators of islet
cell activity. These results support a critical role of MafA in islet
cell function.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |